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Abstract: We explored the association of physical fitness (PF) with pregnancy-related symptoms,
at the 16th and 34th gestational weeks (g.w.). The International Fitness Scale and the Pregnancy
Symptoms Inventory were employed to assess self-reported PF and pregnancy-related symptoms,
respectively. At the 16th g.w. greater self-reported overall PF was associated with lower incidence of
urinary frequency (p = 0.020); greater overall PF, cardiorespiratory fitness (CRF), muscular strength
and speed-agility were associated with lower incidence of tiredness-fatigue (all, p < 0.05); greater
overall PF and speed-agility were associated with lower incidence of poor sleep (both, p < 0.05);
greater CRF and flexibility were associated with lower limitations by tiredness-fatigue (both, p < 0.05);
and greater flexibility was associated with lower limitations by poor sleep (p = 0.021). At the 34th g.w.
greater self-reported overall PF, CRF and muscular strength were associated with lower incidence
of tiredness-fatigue (all, p < 0.05); greater CRF was associated with lower incidence of poor sleep
(p = 0.019); and, greater flexibility was associated with lower incidence of increased vaginal discharge
(p = 0.023). Adequate levels of PF, especially CRF, may help women to cope with the most endorsed
pregnancy-related symptoms and its limitations, especially tiredness-fatigue and poor sleep.
Keywords: International Fitness Scale; gestation; strength; flexibility; cardiorespiratory fitness;
agility; pregnancy discomfort.
1. Introduction
Pregnancy is a physiological stage characterized for physical and psychological
changes that, in the vast majority of women, involve symptoms related to the pregnancy
course [1,2]. In fact, more than thirty physical and psychological symptoms have been
described in normal pregnancies and the most commonly reported symptoms are being
fatigued, increased urinary frequency, pain (such as breast pain, headache or back pain),
vaginal discharge or sleep disruption-insomnia [3–6]. The duration and severity of these
pregnancy-related symptoms vary significantly among women, which may occur through-
out the whole pregnancy course although most notably during either first (early pregnancy)
and third trimester (late pregnancy) [5,7]. These symptoms may cause discomfort and
Int. J. Environ. Res. Public Health 2021, 18, 3345. https://doi.org/10.3390/ijerph18073345 https://www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2021, 18, 3345 2 of 12
negatively affect the pregnant women quality of life [1,8] by limiting their activities of
daily living [5]. Therefore, the early detection of pregnancy-related symptoms and their
limitations in activities of daily living is essential to design alternative therapies aimed at
minimize these negative effects on the pregnancy course progress [1].
Pharmacological treatment may minimize pregnancy-related symptomatology, al-
though is not a desirable and save option due to the potential side effects for the fetus [9].
Consequently, pregnant women are more likely to use non-pharmacological methods to
manage pregnancy-related physical symptoms [5]. In this sense, physical fitness (PF),
and its components, is a powerful health indicator in the general population [10–13] and
the screening of PF in the clinical practice could provide valuable information related to
maternal and fetal health during pregnancy, as previously reported [14–17]. Indeed, PF is
described as "the ability to carry out daily tasks with vigor and alertness, without undue fatigue
and with ample energy to enjoy leisure-time pursuits and to meet unforeseen emergencies" [13],
highlighting “without undue fatigue” as an important element especially during pregnancy,
when fatigue is known as a common symptom. Moreover, health-related PF is composed
of cardiorespiratory function, muscle function (such as muscular strength), motor abilities
(such as agility and speed) and indices of morphology (such as joint flexibility) [13,18].
And the level between each of them can vary from person to person, so all or some of these
components could be related to lower pregnancy-related symptoms, and their impact on
limitations on activities of daily living [13].
When an objective assessment of PF is not available due to time-cost limitations [19],
self-reported PF has been proposed as a feasible and valid alternative in different popu-
lations [20–22], including pregnant women [14,17]. Therefore, the International Fitness
Scale (IFIS) [20] covers the perception of pregnant women on these components of physical
fitness in a few minutes.
Greater self-reported PF levels during pregnancy have been previously associated with
better quality of life [14] and lower pregnancy-related pain [17]. As a result, screening of
self-reported PF during pregnancy could be a useful, quick and inexpensive tool to initiate
an effective non-pharmacological treatment, like adapted physical exercise programs [23].
Therefore, we hypothesized that self-reported PF could be also associated with other
pregnancy-related symptoms that may exert a negative impact on the pregnancy course,
such as increased fatigue, sleep disturbances or urinary frequency. As far as we are aware,
whether greater PF levels during pregnancy may be associated with lower pregnancy-
related symptoms, and their impact on limitations on activities of daily living has not been
reported. Consequently, the aim of the present study was to analyze the association of
self-reported PF level with pregnancy-related symptoms, and its limitations on activities of
daily living along pregnancy.
2. Materials and Methods
2.1. Study Design and Participants
The present cross-sectional study is part of the GESTAFIT project randomized con-
trolled trial, where a novel supervised exercise intervention program was developed. The
complete procedures, the inclusion-exclusion criteria and the sample size calculation of
the project have been published elsewhere [24]. A total of 159 Spanish pregnant women
(32.9 ± 4.6 years old) enrolled in this study in three waves (from November 2015 to March
2017), for feasibility reasons. The participants were recruited by the research team between
the 11–13th gestational week (g.w.), during their first gynecologist checkup at the “San
Cecilio” University Hospital (Granada, Spain). A written informed consent was signed by
all interested participants after being informed about the study aims and procedures.
This study was approved by the Ethics Committee on Clinical Research of Granada,
Regional Government of Andalusia, Spain (code: GESFIT-0448-N-15).
Int. J. Environ. Res. Public Health 2021, 18, 3345 3 of 12
2.2. Procedures
After the recruitment, participants were invited to participate in the study at the Sport
and Health University Research Institute (Granada, Spain). Assessments were carried
out at the 16th and 34th g.w. (±2 weeks). Firstly, participants filled an auto-administered
anamnesis assessing their sociodemographic characteristics and medical and reproductive
history. Subsequently, the participants filled questionnaires assessing their self-reported PF
and the Pregnancy Symptoms Inventory (PSI), among others.
2.3. Sociodemographic and Clinical Data
Sociodemographic data including age, marital status, educational level, working
status and number of children were collected.
2.4. Anthropometry and Body Composition
Body weight and height were assessed using a scale (InBody R20; Biospace, Seoul,
Korea) and a stadiometer (Seca 22, Hamburg, Germany), respectively. Body mass index
(BMI) was calculated as weight (kg) divided by squared height (m2).
2.5. Physical Fitness
The IFIS [20] was employed to assess self-reported PF level. The IFIS is composed of
five Likert-scale questions asking the participants about their perceived overall physical
fitness, CRF, muscular strength, speed-agility and flexibility in comparison with their
non-pregnant counterparts. The participants rated their physical fitness levels as “very
poor = 1”, “poor = 2”, “average = 3”, “good = 4” and “very good = 5” [20]. The IFIS has
been previously validated [14] and used in pregnant population [17].
2.6. Pregnancy Related-Symptoms
The PSI [3], in the Spanish validated version [4], was used to assess the nature and
the frequency of the effects of pregnancy-related symptoms The PSI is a 41-items Likert
inventory, self-administered questionnaire that assesses the pregnancy-related symptoms
and how frequent these symptoms limit the activities of daily living of pregnant women.
Firstly, participants responded to each symptom as “never”, “rarely”, “sometimes” or
“often” occurred. A symptom was considered endorsed if the participant indicated “some-
times” or “often”. Consequently, they completed the second part of the questionnaire
evaluating how affected they were by that symptom, as “not limited at all”, “limit a little”
or “limit a lot” their activities of daily living. A symptom was considered as a limitation if
the participant indicated “limit a little” or “limit a lot”. Previous studies summarized the
prevalence of these symptoms and its limitations as a “top three” [5] or “top four-five” [3,4]
most reported. Therefore, we chose to explore the "top four" most commonly reported
pregnancy-related symptoms [3,4].
2.7. Statistical Analyses
All analyses were performed using the Statistical Package for Social Sciences (IBM
SPSS Statistics for Windows, version 22.0, Armonk, NY, USA) and the level of significance
was set at p ≤ 0.05. Descriptive statistics [mean (standard deviation) for quantitative
variables and number of women (%) for categorical variables] were used to describe base-
line characteristics of the participants. Frequencies of each symptom and limitation were
determined by the number of those women experiencing a particular symptom/limitation.
Linear regression analyses were performed to explore the association of self-reported
overall PF, CRF, muscular strength, speed-agility and flexibility with the “top four” fre-
quently reported pregnancy-related symptoms and limitations in each evaluation (at the
16th and 34th g.w.). We controlled for potential confounding such as maternal age and
BMI. The models were additionally adjusted for the exercise intervention program (control
or intervention group) in those variables assesssed at the 34th g.w., in order to correct
the possible effect of the exercise program performed in the GESTAFIT project [24]. We
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additionally adjusted the models for number of children, and results remained the same
(data not shown).
3. Results
The final sample size was composed of 159 Spanish pregnant women. Nonetheless,
the PSI questionnaire was included in the second wave of recruitment, since we considered
that information meaningful after the pregnancy-symptoms experienced by our pregnant
women and reported to our research team. Therefore, the PSI sample was n = 78, at the
16th g.w., and n = 62, at the 34th g.w. Moreover, some of them did not attend the second
evaluation (at the 34th g.w.) or did not return all the questionnaires duly completed, which
meant a loss of data in some other outcomes (see Figure 1).
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Figure 1. Flow diagram of study participants.
Sociodemographic and clinical characteristics of the participants are shown in Table 1.
The “top four” pregnancy symptoms, reported sometimes or often, at the 16th g.w. were:
urinary frequency (92.3%), tiredness-fatigue (85.9%), poor sleep (74.4%) and breast pain
(70.5%). At the 34th g.w.: poor sleep (91.9%), urinary frequency (90.3%), tiredness-fatigue
(87.1%) and increased vaginal discharge (72.6%). The “top four” frequency of their limita-
tions in activities of daily living at 16th g.w. were: tiredness-fatigue (68.0%), poor sleep
(63.2%), urinary frequency (54.6%) and headache (52.7%). At the 34th g.w.: poor sleep
(83.6%), tiredness-fatigue (80.7%), urinary frequency (64.5%) and back pain (58.9%).
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Table 1. Sociodemographic and clinical characteristics of the participants.
Maternal Characteristics n Mean ± SD
Age (years) 158 32.9 ± 4.6
Height (cm) 157 163 ± 6.21
Weight at the 16th gestational week (kg) 157 67.0 ± 11.8
Weight at the 34th gestational week (kg) 123 74.6 ± 10.8
Body max index at the 16th gestational week (kg/m2) 157 24.9 ± 4.14





Primary or high-school 37 (23.4)
Specialized training 27 (17.1)
University degree 94 (59.5)
Working status 158
Homework/unemployed 48 (30.4)
Partial-time employed/student 41 (25.9)
Full-time employed 69 (43.7)
Parity 158 n (%)
Nulliparous 96 (60.8)
Multiparous 62 (39.2)
Previous abortions 66 (42.0)
Self-reported physical fitness * (1–5)
16th gestational week 158





34th gestational week 117





Top four pregnancy symptoms (0–3) 78 n (%)
16th gestational week
Urinary frequency 72 (92.3)
Tiredness-fatigue 67 (85.9)
Poor sleep 58 (74.4)
Breast pain 55 (70.5)
34th gestational week 62
Poor sleep 57 (91.9)
Urinary frequency 56 (90.3)
Tiredness-fatigue 54 (87.1)
Increased vaginal discharge 45 (72.6)
Top four limitations ** (0–2)
16th gestational week
Tiredness-fatigue 78 53 (68.0)
Poor sleep 76 48 (63.2)
Urinary frequency 77 42 (54.6)
Headache 72 38 (52.7)
34th gestational week
Poor sleep 61 51 (83.6)
Tiredness-fatigue 62 50 (80.7)
Urinary frequency 62 40 (64.5)
Back pain 56 33 (58.9)
SD, Standard Deviation. * Self-reported physical fitness varies from 1 (“very poor”) to 5 (“very good”). ** As the
number of women responding questions varied, the denominator is displayed for each symptom (n). Women
who did not experience any of the symptoms did not answer questions about their limitations.
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The total 41-items self-reported pregnancy symptoms reported sometimes or often,
and the frequency of their limitations in activities of daily living at the 16th and 34th g.w.
are shown in Table S1.
The partial correlations of self-reported overall PF and its components with pregnancy
symptoms and limitations to activities of daily living at the 16th and 34th g.w. are shown
in Table S2.
The linear regression model assessing the association of self-reported overall PF and
its components with the “top four” reported pregnancy-related symptoms and limitations
at the 16th and 34th g.w. are shown in Table 2. At the 16th g.w., greater self-reported overall
PF was associated with lower incidence of urinary frequency (β = −0.30, p = 0.020). Greater
self-reported overall PF, CRF, muscular strength and speed-agility were associated with
lower incidence of tiredness-fatigue (β = −0.31, p = 0.018; β = −0.29, p = 0.018; β = −0.25,
p = 0.031 and β = −0.34, p = 0.006, respectively). Greater self-reported overall PF and
speed-agility were associated with lower incidence of poor sleep (β = −0.46, p < 0.001 and
β = −0.31, p =0.014, respectively). Greater self-reported CRF and flexibility were associated
with lower limitations by tiredness-fatigue (β = −0.34, p =0.006 and β=−0.25, p = 0.035,
respectively). Finally, greater self-reported flexibility was associated with lower limitations
by poor sleep (β = −0.28, p = 0.021).
At the 34th g.w., greater self-reported overall PF, CRF and muscular strength were as-
sociated with lower incidence of tiredness-fatigue (β = −0.32, p = 0.013; β = −0.33, p = 0.012
and β = −0.29, p = 0.032, respectively). Greater self-reported CRF was associated with
lower incidence of poor sleep (β = −0.31, p = 0.019). Finally, greater self-reported flexibility
was associated with lower incidence of increased vaginal discharge (β = −0.31, p = 0.023).
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Table 2. Linear regression coefficients assessing the association of self-reported physical fitness and frequent symptoms and limitations at the 16th and 34th gestational weeks.
Items
Pregnancy Symptoms Limitations
16th Gestational Week 34th Gestational Week 16th Gestational Week 34th Gestational Week
β B SE p β B SE p * β B SE p β B SE p *
Overall physical fitness
Urinary frequency −0.30 −0.22 0.09 0.020 * −0.09 −0.08 0.11 0.486 −0.18 −0.15 0.11 0.177 −0.07 −0.07 0.13 0.586
Tiredness-fatigue −0.31 −0.28 0.12 0.018 * −0.33 −0.32 0.13 0.013 * −0.16 −0.14 0.12 0.246 −0.26 −0.26 0.13 0.052
Poor sleep −0.46 −0.53 0.14 <0.001* −0.26 −0.26 0.13 0.052 −0.14 −0.12 0.12 0.300 −0.05 −0.05 0.14 0.705
Breast pain −0.05 −0.06 0.17 0.709 NA NA NA NA NA NA NA NA NA NA NA NA
Increased vaginal
discharge NA NA NA NA −0.21 −0.26 0.17 0.134 NA NA NA NA NA NA NA NA
Headache NA NA NA NA NA NA NA NA −0.14 −0.13 0.14 0.324 NA NA NA NA
Back pain NA NA NA NA NA NA NA NA NA NA NA NA −0.05 −0.05 0.14 0.742
Cardiorespiratory fitness
Urinary frequency −0.13 −0.08 0.07 0.278 −0.04 −0.04 0.10 0.728 −0.24 −0.17 0.09 0.059 0.10 0.10 0.12 0.436
Tiredness-fatigue −0.29 −0.22 0.09 0.018 * −0.33 −0.30 0.11 0.012 * −0.34 −0.26 0.09 0.006 * −0.21 −0.19 0.12 0.120
Poor sleep −0.20 −0.19 0.12 0.108 −0.31 −0.28 0.12 0.019 * −0.04 −0.03 0.09 0.769 −0.04 −0.03 0.12 0.779
Breast pain −0.07 −0.07 0.13 0.593 NA NA NA NA NA NA NA NA NA NA NA NA
Increased vaginal
discharge NA NA NA NA −0.24 −0.28 0.15 0.076 NA NA NA NA NA NA NA NA
Headache NA NA NA NA NA NA NA NA −0.15 −0.12 0.11 0.252 NA NA NA NA
Back pain NA NA NA NA NA NA NA NA NA NA NA NA −0.18 −0.18 0.13 0.182
Muscular strength
Urinary frequency −0.09 −0.06 0.08 0.44 0.06 0.06 0.11 0.611 −0.10 −0.08 0.10 0.415 −0.07 −0.07 0.13 0.586
Tiredness-fatigue −0.25 −0.22 0.10 0.031 * −0.29 −0.27 0.12 0.032 * −0.20 −0.17 0.10 0.094 −0.22 −0.21 0.13 0.102
Poor sleep −0.20 −0.22 0.13 0.089 −0.07 −0.07 0.13 0.584 0.01 0.01 0.10 0.939 −0.20 −0.18 0.13 0.153
Breast pain 0.03 0.04 0.14 0.802 NA NA NA NA NA NA NA NA NA NA NA NA
Increased vaginal
discharge NA NA NA NA 0.05 0.06 0.17 0.720 NA NA NA NA NA NA NA NA
Headache NA NA NA NA NA NA NA NA −0.10 −0.09 0.12 0.450 NA NA NA NA
Back pain NA NA NA NA NA NA NA NA NA NA NA NA −0.14 −0.14 0.14 0.328




16th Gestational Week 34th Gestational Week 16th Gestational Week 34th Gestational Week
β B SE p β B SE p * β B SE p β B SE p *
Speed-agility
Urinary frequency 0.16 0.11 0.08 0.189 0.10 0.09 0.10 0.407 0.22 0.17 0.10 0.085 0.03 0.03 0.12 0.801
Tiredness-fatigue −0.34 −0.28 0.10 0.006 * −0.18 −0.16 0.12 0.193 −0.18 −0.15 0.11 0.163 −0.15 −0.14 0.12 0.255
Poor sleep −0.31 −0.32 0.13 0.014 * −0.06 −0.06 0.12 0.643 −0.15 −0.12 0.10 0.254 −0.05 −0.04 0.12 0.727
Breast pain 0.18 0.21 0.15 0.114 NA NA NA NA NA NA NA NA NA NA NA NA
Increased vaginal
discharge NA NA NA NA −0.15 −0.17 0.15 0.290 NA NA NA NA NA NA NA NA
Headache NA NA NA NA NA NA NA NA −0.09 −0.09 0.13 0.481 NA NA NA NA
Back pain NA NA NA NA NA NA NA NA NA NA NA NA 0.05 0.04 0.13 0.727
Flexibility
Urinary frequency −0.09 −0.05 0.07 0.456 −0.16 −0.12 0.09 0.203 −0.06 −0.04 0.08 0.619 −0.16 −0.13 0.11 0.223
Tiredness-fatigue −0.15 −0.10 0.08 0.213 −0.10 −0.08 0.10 0.450 −0.25 −0.18 0.08 0.035 * −0.04 −0.03 0.11 0.766
Poor sleep −0.02 −0.02 0.11 0.854 −0.20 −0.16 0.11 0.143 −0.28 −0.19 0.08 0.021 * −0.15 −0.12 0.10 0.267
Breast pain −0.14 −0.14 0.12 0.260 NA NA NA NA NA NA NA NA NA NA NA NA
Increased vaginal
discharge NA NA NA NA −0.31 −0.31 0.13 0.023 * NA NA NA NA NA NA NA NA
Headache NA NA NA NA NA NA NA NA −0.08 −0.07 0.10 .517 NA NA NA NA
Back pain NA NA NA NA NA NA NA NA NA NA NA NA −0.13 −0.10 0.11 0.358
* (Significant values, p < 0.05). β, standardized regression coefficient; B, non-standardized regression coefficient; SE, Standard Error. Model adjusted for maternal age, body max index at the 16th or 34th
gestational weeks and exercise intervention at the 34th gestational week. NA, not applicable.
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4. Discussion
Our findings indicate that greater overall self-reported PF was associated with less
incidence of pregnancy-related symptoms and its limitations in activities of daily living.
Specifically, greater self-reported overall PF, CRF, muscular strength and speed-agility were
associated with lower incidence of tiredness-fatigue. Moreover, greater self-reported overall
PF, CRF and speed-agility were associated with lower incidence of poor sleep. Attending
its limitations on activities of daily living, greater self-reported CRF and flexibility were
associated with less tiredness-fatigue during the early second trimester of pregnancy.
The mean age of the women at the time of the recruitment was 32.9 ± 4.6 years old
(in the average of Spaniards pregnancy age [25]). Pregnant women showed average level
of overall self-reported PF and all its components throughout the pregnancy course. Top
prevalence of pregnancy-related symptoms reported by our sample of pregnant women
were similar to those found in the original PSI version [3], the Spanish-validated version [4],
and other studies investigating pregnancy-related symptoms [5,7]. In our study, tiredness-
fatigue and poor sleep were specially reported as endorsed pregnancy-related symptoms
and limitations in activities of daily living along the pregnancy course. The findings of the
present study shown that greater PF levels were associated with lower incidence of these
two commonly reported pregnancy-related symptoms.
Fatigue has been associated with pregnancy complications and fears, such as depres-
sion, risk of caesarean section, fear of childbirth and weak maternal-infant attachment,
which may seriously impact materno-fetal health and quality of life [8]. Moreover, physical,
anatomical, physiological and hormonal changes associated with pregnancy, fetal move-
ments and the size of the uterus, may negatively affect sleep patterns [5,7]. In addition, a
high percentage of pregnant women experience fatigue in all trimesters [5], aggravated
also by sleep disruptions [5].
Other symptoms, such as increased urinary frequency and vaginal discharge are
common urogenital system complaints throughout pregnancy [5], also confirmed in our
study sample. The integumentary and vascular systems involve altered levels of circulating
hormones, increased intravascular volume, and compression from the enlarging uterus
underlie the complex physiological adaptations to the pregnancy course [26], which may
also contribute to poor sleep and increased fatigue feelings. Insomuch as these pregnancy-
related changes/symptoms are interconnected, it is plausible that improving some of
them may also exert a positive impact on others. In this sense, our results show that
pregnant women with greater self-reported overall PF levels and its components may
experience both, lower incidence and lower limitations in activities of daily living due to
tiredness-fatigue and poor sleep.
Since our study is the first to analyze the relationship of PF levels with pregnancy-
related symptoms, it is not possible to compare the present findings with other similar stud-
ies. Nevertheless, pregnancy-related symptoms that caused the largest effect on women’s
lives such as fatigue-tiredness, sleep disruptions-insomnia, and increased urination need
to be deeply explored and understood, preventing women from taking unnecessary phar-
macological treatment. Some possible hypothesis about the mechanisms involved in these
associations could be proposed. Regarding fatigue-tiredness, there is a lack of studies
exploring the influence of PF on fatigue during pregnancy. In general population, greater
physical activity levels have been associated with about 40% reduced risk in experiencing
low energy and fatigue [27]. In pregnant women, a recent systematic review and meta-
analysis concluded that following a supervised exercise program during pregnancy reduces
fatigue [8]. Moreover, a previous study, conducted in general population, showed that
those participants with lower self-reported PF had poorer sleep quality [28]. Specifically,
poor sleep quality was associated with lower levels of muscular strength, CRF and flexibil-
ity [29]. Our results showed that those pregnant women with greater self-reported overall
PF (especially CRF and speed-agility) reported lower incidence of poor sleep. Moreover,
those with greater self-reported flexibility also reported lower limitations due to poor
sleep. Although further research is needed to elucidate the mechanisms, a possible expla-
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nation promoting reduced fatigue and better sleep quality is that exercise plays a role in
brain circuitry, neurotransmitters and neuromodulators, regulating motor functioning and
mediating mood disturbances, through monoamines, histamine or gabapentin-mediated
neurotransmission [27]. In addition, exercise plays a role in the thermoregulatory mech-
anism, improving vasodilation, decreasing cortisol levels or exerting well-being and a
mental-calm state [28], consequently decreasing sleep disturbances.
Regarding urogenital problems, one possible explanation is that pregnant women
may have a weak pelvic floor, as it has been studied that a higher BMI is associated with
weaker pelvic floor muscles [30], and our participants had an average BMI of 25 kg/ m2 at
the 16th g.w. Moreover, lower PF levels may also exert a negative effect, especially in the
later stages of pregnancy, due to the pressure of the growing fetus on the muscles of the
utero muscles [31]. In fact, other factors, such as low PF levels and sleep disturbances are
also significant contributors to the development of fatigue [32].
Greater PF levels are improved by practicing physical activity or exercise [23,33]. The
specialized 2019-Canadian Guidelines for physical exercise during pregnancy indicate
that “there may be periods when following the guidelines is not possible due to fatigue
and/or discomforts of pregnancy” [23]. In fact, common barriers to be physically active
during pregnancy include discomforts of pregnancy, among others [34]. Nevertheless, our
results suggest that pregnant women with greater self-reported PF levels may suffer from
lower frequency and severity of these pregnancy-related symptoms, such as fatigue and
discomfort. Therefore, we encourage pregnant women to reach greater PF levels in order
to deal with these symptoms and limitations through pregnancy course, although some
modification to exercise routines may be necessary [33]. In this sense, women should ac-
complish with at least 150 min of moderate intensity physical activity per week, combining
aerobic, resistance-strength activities plus pelvic floor training, to obtain meaningful health
benefits and reductions in pregnancy-related complications [23]. This should be especially
mandatory during pregnancy since we have previously found that only 22% of the Spanish
pregnant women complied with these recommendations [35].
Some limitations of the present study should be acknowledged. Firstly, the cross-
sectional design precludes determination of causality. For instance, it is possible that
women with greater tiredness-fatigue are less likely to be physically active or vice-versa [34]
(although changes in physical fitness levels need time to increase/decrease, not fluctuating
acutely). Moreover, our study sample was relatively small, mainly due to the design of
the PSI, which allows to answer only if the symptom is considered as frequent [3,4], and
the fact that we did not included this questionnaire in our first recruitment wave [24].
Regarding strengths, most studies until date have only assessed a few pregnancy-related
symptoms, while we have measured a wide range of them (41 pregnancy-related symptoms
and limitations).
5. Conclusions
Greater self-reported overall PF and its different components, especially CRF, have
shown a strong relationship with lower incidence and limitations of the most common
pregnancy-related symptoms, particularly tiredness-fatigue and poor sleep. Pregnant
women may benefit from exercise programs focused on improving PF in order to experience
a less unpleasant pregnancy due to these symptoms. Moreover, health care providers,
physical therapists and physical exercise specialists should screen PF levels and encourage
pregnant women to reach adequate PF levels during this stage.
Supplementary Materials: The following are available online at https://www.mdpi.com/1660
-4601/18/7/3345/s1, Table S1: Prevalence of self-reported pregnancy symptoms and limitations
to activities of daily living at 16th (n = 78) and 34th (n = 62) gestational weeks. Table S2: Partial
correlations of self-reported overall PF and its components with pregnancy symptoms and limitations
to activities of daily living at the 16th and 34th gestational weeks.
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